A novel geometry has been proposed for a hybrid magnetic resonance imaging ͑MRI͒-linac system in which a 6 MV linac is mounted on the open end of a biplanar, low field ͑0.2 T͒ MRI magnet on a single gantry that is free to rotate around the patient. This geometry creates a scenario in which the magnetic field vector remains fixed with respect to the incident photon beam, but moves with respect to the patient as the gantry rotates. Other proposed geometries are characterized by a radiation source rotating about a fixed cylindrical magnet where the magnetic field vector remains fixed with respect to the patient. In this investigation we simulate the inherent dose distribution patterns within the two MRI-radiation source geometries using PENELOPE and EGSnrc Monte Carlo radiation transport codes with algorithms implemented to account for the magnetic field deflection of charged particles. Simulations are performed in phantoms and for clinically realistic situations. The novel geometry results in a net Lorentz force that remains fixed with respect to the patient ͑in the cranial-caudal direction͒ and results in a cumulative influence on dose distribution for a multiple beam treatment scenario. For a case where patient anatomy is reasonably homogeneous ͑brain plan͒, differences in dose compared to a conventional ͑no magnetic field͒ case are minimal for the novel geometry. In the case of a lung plan where the inhomogeneous patient anatomy allows for the magnetic field to have significant influence on charged particle transport, larger differences occur in a predictable manner. For a system using a fixed cylindrical geometry and higher magnetic field ͑1.5 T͒, differences from the case without a magnetic field are significantly greater.
I. INTRODUCTION
The pursuit of real time image guidance in adaptive radiotherapy has led some investigators to consider the possibility of merging a megavoltage radiation therapy linear accelerator ͑linac͒ or a 60 Co teletherapy unit with a magnetic resonance imaging ͑MRI͒ system. [1] [2] [3] [4] [5] [6] [7] [8] [9] As a direct result of any of the proposed designs, megavoltage ͑MV͒ photon beams would be delivered to a patient in the presence of a static magnetic field ͑B 0 ͒. Because the mechanisms by which radiation deposits energy inside of a medium are governed by the transport and interaction of charged particles with that medium, the magnetic field of the MRI will modify the trajectories of the charged particles thus modifying the absorbed dose distributions. 10 It has been demonstrated that a B 0 field can alter the dose deposition characteristics of a 6 MV photon beam, both in homogeneous and inhomogeneous media through the deflection of secondary charged particles. [4] [5] [6] [10] [11] [12] [13] The literature has concentrated mostly on model problems involving slab phantoms in a specific operational geometry, [4] [5] [6] [7] although one study has considered a patient case. 14 Four groups worldwide have proposed methods to integrate either a linear accelerator or a 60 Co source with a MRI. [1] [2] [3] 8 These four proposals can be grouped into two basic geometries. The first geometry [1] [2] [3] can be summarized as a solenoidal and stationary MRI whose B 0 field is along the direction of the solenoid, which is also parallel to the cranialcaudal direction of the patient. The radiation source ͑linac or 60 Co͒ rotates around the MRI in a transverse plane. Lagendijk et al. have proposed a B 0 field strength of 1.5 T.
3,4,6,7 Other groups proposing somewhat similar ar-rangements of 60 Co sources in this geometry 1,2 have yet to firmly establish the B 0 field strength in their systems, although Kron et al. have suggested a value of 0.25 T. 2 This geometry is henceforth referred to as a fixed cylindrical ͑FC͒ geometry. The second geometry 8 instead uses a biplanar, low field ͑0.2 T͒ MRI and an irradiator ͑linac͒ that is coupled to one open end of the system ͓see Figs. 1͑a͒ and 1͑b͔͒. The entire system rotates around the patient, allowing beams to be delivered from any angle. We shall refer to this as the rotating biplanar ͑RBP͒ geometry.
Each of the two geometries has fundamentally different dose deposition distributions when the gantry of the radiation source rotates around the patient because of the different orientations of the static magnetic field, B 0 with respect to radiation beam and the patient. For the RBP geometry, during rotation of the gantry, the direction of the B 0 magnetic field is always perpendicular with respect to the incident photon direction but changes with respect to the patient geometry. For the FC geometry, during rotation of the gantry, the direction of the B 0 magnetic field changes with respect to the direction of the radiation beam, but remains fixed with respect to the patient.
The changes of the dose deposition due to the different geometries can be understood in the following manner. For simplicity, Fig. 1 shows the direction of the resultant Lorentz force on secondary electrons moving in the direction of the photon beam incident on the patient both in RBP and FC geometries. Using the right hand rule, it is easily understood that the direction of the Lorentz force stays the same with respect to the patient for different incident photon beam directions in the RBP geometry while it changes in the FC geometry. As a result, the magnetic field influence on the resultant dose distribution patterns in the patient is different in the two geometries.
The purpose of this investigation is to describe the inherent differences of dose distribution patterns of the two MRIradiation source geometries and show the result of these differences in clinically realistic situations. In addition to the single and parallel opposed beams incident on an inhomogeneous slab geometry phantom, brain and lung CT geometries with multiple incident beams are chosen because these represent the two extreme examples of tissue homogeneity. The effects of a magnetic field on the dose deposition pattern may not be significant in the brain case, which is relatively homogeneous, but the effects may be significant at the tissue inhomogeneities that exist within a lung case. In this work, we specifically consider the dose distributions resulting from these irradiation geometries by using the MRI magnetic fields that have been reported for each of the geometries: i.e., the RPB geometry with ͉B 0 ͉ = 0.2 T and the FC geometry with ͉B 0 ͉ = 1.5 T using a 6 MV source. Some simulations are also performed using a 60 Co source.
II. METHODS

II.A. Monte Carlo simulations in the presence of a magnetic field
We used two separate Monte Carlo codes: PENELOPE 15, 16 and EGSnrc. [17] [18] [19] The codes have been adapted somewhat from their default, published forms to incorporate the influence of external magnetic fields on charged particle transport. Two codes were used at separate stages in this work, both to provide a consistency check of results and to exploit the advantages offered by each code system for different aspects of this work. PENELOPE and its user-code penEasy 20 offered a more exact treatment of the magnetic field influence on transport and a lower cutoff energy for charged particle transport, and the EGSnrc user-code DOSXYZnrc 21 offered the ability to easily perform calculations within a CTdefined voxelized geometry.
PENELOPE has been extensively tested in the literature without the presence of magnetic fields. 15, 22, 23 A detailed description of PENELOPE's tracking algorithm for the transport of charged particles in the presence of static electromagnetic fields is given in Appendix C of the PENELOPE manual. 16 This algorithm is implemented in the penfield.f subroutine and was used in this work with the appropriate magnetic field parameters. The algorithm allows for exact tracking of charged particles ͑irrespective of step length͒ within a uniform magnetic field. For each transport step, the displacement and velocity change of charged particles due to the magnetic field alone are accounted for by calculating the Lorentz force's influence on the particle's trajectory. It is assumed that the effect of the magnetic field can be accounted for independently of the transport step that would take place without the presence of a magnetic field. Consequences to a particle's stopping power due to synchrotron radiation, which have been demonstrated to be insignificant for most medical physics applications 10 are ignored. Chen et al. 24 have demonstrated that PENELOPE, when configured with the penfield.f subroutine, reliably reproduces dose distributions to a plastic phantom in the presence of a nonuniform magnetic field with a peak strength of 3 T. The usercode penEasy 20 allows the user to write a steering file that defines the source and tally parameters for the PENELOPE simulation; the transport of photons and charged particles remains the same. The parameters used to perform the simulations were as follows: W cc = 60 keV and W cr = 6 keV representing the cutoff thresholds for the hard inelastic collisions and radiative events, respectively; C 1 = 0.1 defining the fraction by which the mean free path for hard elastic events can be defined by the first transport mean free path at high energies; and C 2 = 0.1 defining the maximum average fractional energy loss between consecutive hard elastic collisions. The values adopted for these parameters offered reasonable simulation efficiency and altering them has only a weak influence on the results. 16 EGSnrc is published with a macro package called emf_macros.mortran, which is an updated but not completely implemented copy of the macros developed for EGS4 by Bielajew. 10 This macro is invoked after the completion of a conventional charged particle step. In general, the accurate simulation of charged particle transport within electromagnetic fields requires that the step sizes within the condensed history algorithm be sufficiently short to ensure that: ͑a͒ the change in the magnitude of the electromagnetic field across a step is small, ͑b͒ the relative change in the particle's kinetic energy remains small, and ͑c͒ the relative change in the particle's direction of motion is small, where small is on the order of 5% or less. 16 Items ͑a͒ and ͑b͒ are easily achievable because the magnetic fields simulated are always uniform, and the magnetic field does not change the particle's energy. Item ͑c͒, however, remains a concern. From the EGS4 macros, step size is restricted to 0.02m e c 2 / ͑100͉B Ќ ͉q e c͒ cm or less, where m e c 2 is the electron's rest mass, c is the speed of light, q e is the charge of an electron, and ͉B Ќ ͉ is the magnitude of the magnetic field ͑in tesla͒ perpendicular to the particle's velocity. The value 0.02 is a user-defined parameter corresponding to a 2% change in direction over the transport step. For electrons traveling perpendicular to the magnetic field lines, this restricts the step size to approximately 0.17 and 0.0023 cm for 0.2 and 1.5 T fields, respectively. No additional limitation was introduced to deal with the multiple scattering treatment of charged particles applied in EGSnrc, which potentially introduces an approximation into the results, i.e., large angle deflections introduced by multiple scattering may still occur. However, we note that for the slab phantom cases presented here, PENELOPE and EGSnrc dose predictions were generally in agreement to within statistical uncertainty ͑ϳ1%͒. Transport cutoffs for the EGSnrc simulations were set for electrons to AE= ECUT= 0.7 MeV ͑rest mass+ kinetic energy͒ and for photons to AP= PCUT = 0.01 MeV.
II.B. Slab phantoms
To understand the dosimetric implications of the single and parallel opposed fields in the presence of uniform magnetic field, we first considered the relative absorbed dose to medium for a simple, inhomogeneous slab geometry analogous to ͑but not identical to͒ that of Raaijmakers et al. 4 A diagram of the slab geometry is presented in Fig. 2 . The influence of the magnetic field on the electron trajectories is stronger in lower density media ͑as density decreases we expect the electron trajectories to approach the curved paths seen in a vacuum scenario͒. A direct consequence of this is the "electron return effect" where dose to the tissue near tissue-air interfaces can be substantially enhanced by electrons returning to the tissue as a result of the magnetic field bending their trajectory. 4 The magnitude of this effect is dependent on the magnetic field strength, the electrons' velocities and the patient anatomy and geometry. We created a virtual phantom consisting of semi-infinite slabs of water, ICRP lung ͑with mass density of 0.3 g / cm 3 and chemical composition as defined by NIST͒, 25 and water sandwiched in air. This geometry is useful in investigating the dosimetric consequences of tissue inhomogeneities in a magnetic field. We chose ICRP lung as a central material instead of air so as to understand the consequences of the magnetic field on dose using a realistic low density tissue. Slabs of air are explicitly defined on either side of the phantom because PENELOPE does not incorporate magnetic field effects into its vacuum transport algorithm. For these simulations ͑performed both with PENELOPE and EGSnrc codes͒ we considered FIG. 2. The slab phantom geometry. A 6 MV parallel spectrum is incident on a series of semi-infinite slabs consisting of air, ICRP lung, and water. The magnetic field was uniform throughout the phantom, defined at 0.0, 0.2, and 1.5 T. We considered both single fields and parallel, opposing fields. In the RBP geometry, B 0 switches direction for the opposing beam. Air slabs of 10 cm thickness are introduced on either side to force PENELOPE's magnetic field algorithm which is not invoked in vacuum.
5 ϫ 5 cm 2 photon fields with parallel ͑nondiverging for simplicity͒ incidence comprised of a 6 MV central axis spectrum for a Varian linac. 26 Additional EGSnrc simulations were performed with the 6 MV spectrum replaced by the 60 Co spectrum published by the EGSnrc development group. 19 We considered parallel opposing beams, in addition to single beams ͑as shown in Fig. 2͒ . For single fields the B 0 field vector points out of the page. For parallel opposing beams, the B 0 field vector changes sign ͑rotation through rad͒ in the RBP geometry generating net Lorentz force vectors that point in the same direction for downstream-traveling electrons. In the FC geometry, since the direction of the magnetic field is fixed, the net Lorentz force vectors are in opposite directions for the two beams.
For our simulations we considered magnetic B 0 field magnitudes of: 0.0 T-as a no-field base line, 0.2 T-as proposed for the RBP design 8 and as a representative lower field strength for the FC geometry, and 1.5 T-as one group has proposed for the FC geometry. 3 Dose scoring voxels were defined as 0.2ϫ 0.2ϫ 1.0 cm 3 in size, the larger ͑1.0 cm͒ dimension being in the y direction, parallel to the magnetic field vector, but perpendicular to the beam directions and the Lorentz force. Doses were normalized to the depth of maximum dose for the ͉B 0 ͉ = 0.0 T case. Parallel opposing beams were assigned equal weights. An adequate number of histories were run in each simulation to keep the statistical uncertainty for dose to water voxels along the central axis below 1%.
II.C. Patient phantoms
While the general effects of a magnetic field on dosimetry can be modeled using a simplified slab geometry, the ultimate goal in this work was to understand the consequences of a B 0 field in the particular geometries proposed on the dose distribution in a real patient. For this purpose, we considered two representative scenarios. The first was a four field treatment plan developed for dose delivery to a brain in simulation of a glioblastoma multiform treatment, a case in which ͑aside from the bony anatomy of the skull͒ the anatomy is reasonably homogeneous. For this scenario we used four equally weighted orthogonal beams ͑anterior, posterior, and two lateral fields͒, each shaped using blocks to conform to the target volume. The second was a lung case, representative of a highly inhomogeneous anatomy where the magnetic field would have strong influence on electrons traveling through low density volumes. For this scenario we applied five equally weighted beams ͑incident at gantry angles of 356°, 176°, 51°, 320°, and 280°͒.
For both cases, plans were developed using the Eclipse treatment planning system ͑TPS͒ ͑Varian Oncology Systems, Palo Alto, CA͒. Plan files, including CT data, were exported from the TPS and imported into an in-house Monte Carlo ͑MC͒ treatment planning dose verification system. 27, 28 The system simulates the head of a 6 MV linac ͑model parameters were specific to the head of a Varian 21EX linac͒, storing BEAMnrc output as a phase space file scored at a plane 70 cm from the source for each separate beam. The system also generates its own model of the patient based on a CT image set using an in-house CT number-to-mass density conversion table. The body structure contours were imported from the DICOM RT structure set file and used to mask the virtual phantom such that all voxels outside the patient anatomy ͑including patient immobilization system and couch͒ were assigned values for air. Each beam orientation was simulated separately and the results were combined and normalized to 100% at isocenter for the ͉B 0 ͉ = 0.0 T case ͑absolute dose can be obtained by multiplying all voxel doses by the dose-to-isocenter/100%͒. Voxel dimensions were taken from the TPS at 0.25ϫ 0.25ϫ 0.30 cm 3 ͑larger in the cranio-caudal direction͒. The dose to any voxel with a mass density of less than 0.01 g / cm 3 was set to 0 to avoid reporting doses to regions outside the body ͑i.e., air͒. Statistical uncertainty from each beam at the isocenter was Ͻ2%, resulting in uncertainty in the combined dose at the isocenter Ͻ1%. A local mean ͑nearest 6 voxels in 3D͒ smoothing algorithm was applied to further reduce statistical fluctuations.
III. RESULTS
III.A. Slab phantoms
We first consider the relative dose to our lung slab phantom in response to a single, nondiverging 6 MV 5 ϫ 5 cm 2 beam along the central axis, shown in Fig. 3 . All calculated dose distributions are presented relative to dose at the depth of maximum dose calculated without magnetic field. Dose results from the EGSnrc simulations ͑black͒ are within 1% of the PENELOPE results ͑gray͒ at all magnetic field strengths. These results illustrate the potential difference in dose profiles near water-lung interfaces due to modifications to charged particle trajectories introduced by the magnetic field, as introduced by Raaijmakers et al. 4 Our results at 1.5 T appear to be in agreement with those of Raaijmakers et al. 4 given that our phantom incorporated 10 cm of ICRP lung T there is a clear, substantial increase ͑ϳ40%͒ in dose at the water-to-lung boundary and a decrease ͑ϳ25%͒ in the lung-to-water boundary. At 0.2 T, slight differences of only ϳ2% are seen. Dose to air is not shown.
instead of 2 cm of air between water slabs. We note that the results of Raaijmakers et al. were experimentally verified. 5 Along the central axis for a single beam, there will be essentially no difference between the FC and RBP geometries, as the Lorentz force is perpendicular to the beam in both cases. For the 1.5 T field strength, at the water-to-lung interface the simulations indicate a relative dose increase of up to 28% to water and up to 40% to lung and at the lung-to-water interface a relative dose decrease of up to 26% to lung and up to 24% to water. There are also notable differences in the buildup region and at the exit region ͑last centimeters of water in the second water slab͒. For a field strength of 0.2 T, dose differences relative to the 0.0 T field are generally within Ϯ2.5% along this axis, with exit dose increased by 5% in the last voxel of water.
Extending the picture we looked at dose along a plane perpendicular to the magnetic field through the beam's central axis in the slab phantom for single fields using both 6 MV and 60 Co spectra. The results of the EGSnrc simulations using magnetic field magnitudes of 0.0 and 0.2 T are shown in Fig. 4 . Doses have been normalized independently for each spectrum to the central axis dose maximum for the ͉B 0 ͉ = 0.0 T case. In general, dose distribution differences are characterized by a slight shift in the direction of the Lorentz force ͑upwards in Fig. 4 .͒ in the lung tissue, along with an electron return effect dose enhancement at the exit surface of approximately 20% for both spectra. Because the 6 MV incident photon spectrum gives rise to an electron spectrum with higher energies compared to the 60 Co source, the dose differences for the 6 MV case are spread out over a larger area and are slightly larger in magnitude.
The EGSnrc dose results along the beam central axis plane resulting from a parallel opposing pair on the same slab phantom are shown in Fig. 5 . We determined that PENELOPE results for the 6 MV cases ͑not shown͒ are in general agreement with the EGSnrc results ͑within ϳ Ϯ 1%, with maximum differences up to 3% in regions most strongly influenced by the magnetic field in the 1. geometry. The simulation was done in this manner to better compare the two situations on the plane containing the Lorentz force which represents a coronal plane for the RBP geometry and transverse plane for the FC geometry for the patient orientation depicted in Fig. 1 . Therefore, in the actual patient geometry, the top of the figure would represent the patient inferior for the RBP geometry ͓Figs. 5͑b͒ and 5͑d͔͒ and the patient posterior for the FC geometry ͓Figs. 5͑c͒ and 5͑e͔͒.
It is immediately apparent that for the RBP geometry this situation of opposing beams results in a scenario where the dose modifications due to the magnetic field are adding constructively. This is not surprising if one considers that the net Lorentz force on a forward-peaked electron velocity distribution ͑pointing downstream͒ is in the same direction for both beams since the relative orientation of the photon beam with respect to the magnetic field remains fixed. In this case the Lorentz force is pointing toward the top of the figure for both beams, and thus we see a slight shift in the dose distribution toward the top of the figure. The shift is more pronounced in the lung material, as the electrons have a longer mean free path in the lower density material. As a result, in the lung tissue we see a dose increase at one field edge and a decrease at the other of up to 12%. As observed in the single beam there are small differences in dose at the water-lung interface for the 0.2 T case, therefore, in the opposed case these small hot and cold spots come very close to canceling each other completely, leaving very minimal differences at the interfaces.
In the FC geometry the net Lorentz force ends up being in opposite directions for the two beams. The difference maps ͓somewhat in Fig. 5͑e͒ and more strongly in Fig. 5͑f͔͒ show hot and cold spots due to asymmetry in the dose deposition. For the higher field strength ͉͑B 0 ͉ = 1.5 T͒, the hot spot at the water to lung interface as seen in the single beam geometry is not fully compensated by the cold spot at the lung to water interface of the opposing beam. Therefore, along the central axis we still see significant hot spots as the beams enter the lung material. Similarly, the hot and cold spots that occur in the buildup/exit regions do not cancel thus leaving hot spots near the surface of up to +22% over several millimeters ͑mm͒. Along the beam edges, since the Lorentz force is in opposite directions for the two beams, the net effects will tend to cancel each other to a certain extent. However, due to the lower and lower fluence of electrons available as the beam travels through the phantom, this cancellation cannot be exact. For example, at 14 cm depth in Fig. 5͑c͒ , more electrons are available to be pushed upward in the beam entering from the left hand side than the electrons available to be pushed downward in the beam entering from the right hand side. Of course, this lack of cancellation is accentuated at the higher field strength and one observes narrow regions of both hot and cold doses near the field edge in the lung material. These observations are still somewhat apparent for the low field 60 Co case, but result in differences below 2%. The increase in dose at the exit surfaces is still apparent for both magnetic field strengths.
III.B. Patient phantoms
In general, the results from the patient models reinforce those observed in the slab phantoms. The results of EGSnrc simulations for the four field brain plan are illustrated in Fig.  6 . Figures 6͑a͒ and 6͑b͒ show the combined, relative dose ͑normalized to the dose at the isocenter͒ from all four beams in the absence of an external magnetic field in the transverse and sagittal planes through central axis. Figures 6͑c͒ and 6͑d͒ consider the difference in dose ͑D 0.2 T − D 0.0 T ͒ between irradiation in the RBP geometry with ͉B 0 ͉ = 0.2 T and in the conventional geometry with ͉B 0 ͉ = 0.0 T in the transverse and sagittal planes, respectively. Similarly, Figs. 6͑e͒ and 6͑f͒ consider the difference in dose ͑D 1.5 T − D 0.0 T ͒ between irradiation in the FC geometry with ͉B 0 ͉ = 1.5 T and the conventional geometry with ͉B 0 ͉ = 0.0 T. Because of the homogeneous nature of the brain tissue, dose differences in both configurations are small ͑compared to those seen for the lung plan͒. For the RBP geometry with ͉B 0 ͉ = 0.2 T we see hot spots of +4% ͑maximum͒ and cold spots that are no worse than −2%. We note that there is some increase in the surface dose to skin inferior to the beam entry regions. This is the result of electrons following large arcs ͑a few centimeters in radius͒ after exiting the patient anatomy. In the FC geometry with ͉B 0 ͉ = 1.5 T the exiting electron trajectories travel through tighter arcs and result in surface hot spots of +10% ͑maximum͒ that extend several mm into the patient. Cold spots down to −5% are seen along the geometric edges of the beams. Rerunning the FC geometry with the magnetic field strength reduced to ͉B 0 ͉ = 0.2 T, the maximum and minimum relative dose differences were similar in magnitude to those seen for the RBP geometry ͑results not shown͒.
In Fig. 7 we consider the results of our five field lung plan. Figures 7͑a͒ and 7͑b͒ show the relative dose ͑normal-ized to isocenter͒ when the simulation is performed without any external magnetic field. The difference maps in Figs. 7͑c͒ and 7͑d͒ show the D 0.2 T − D 0.0 T differences in the transverse and sagittal planes, respectively, for irradiation in the RBP geometry with ͉B 0 ͉ = 0.2 T compared to the no magnetic field case. Likewise, the difference maps in Figs. 7͑e͒  and 7͑f͒ show the D 1.5 T − D 0.0 T differences in the transverse and sagittal planes, respectively, for irradiation in the FC geometry with ͉B 0 ͉ = 1.5 T compared to the no magnetic field case. In the RBP ͉B 0 ͉ = 0.2 T geometry the most significant hot and cold spots ͑Ϯ12%͒ are seen in the sagittal view at the edges of the field. Unlike the anatomy within the brain, the low density tissue and air within the lungs allows for the magnetic field to more strongly influence the electron trajectories, even at this low field strength. Dose increases toward the patient's inferior. In comparison, the D 1.5 T − D 0.0 T differences reveal hot spots as high as +30% and cold spots as low as −15% near tissue-lung boundaries and along beam edges. In comparison the differences at the tissue lung boundaries are quite minimal in the RBP geometry at 0.2 T. When the simulation using the FC geometry was rerun with ͉B 0 ͉ = 0.2 T, hot and cold spots of similar magnitude ͑Ϯ12%͒ to those seen for the RBP geometry were seen, again with the general pattern being a shift of dose distribution in the direction of the Lorentz force ͑results not shown͒.
IV. DISCUSSION
The work presented here has been cross validated using two different MC codes, but the results have not been directly measured at this time. As mentioned, PENELOPE has demonstrated reliable results compared to measurement in the presence of a magnetic field. 24 If we modify our slab phantom and source model to approximate the experiment performed by Raaijmakers et al., 5 on a poly͑methyl-methacrylate ͒ PMMA-air-PMMA phantom, we find that the EGSnrc code is able to reproduce their central axis depth profiles ͑which they measured using GafChromatic film͒ for magnetic field strengths of 0.6 and 1.3 T to within reasonable resolution ͑ϳ2% / 2 mm of curves published by Raaijmakers et al. 5 ͒ Thus, we can be confident that the results presented in this work are reasonably valid. At this time, the hybrid MRIradiotherapy systems discussed in this work are under various stages of construction, and as prototype models come online we can expect more rigorous experimental investigations of dosimetry in the presence of magnetic fields.
As can be seen from all of the comparisons presented, the net influence of the magnetic field in either geometry is to cause a shift of the dose distribution in the direction of the Lorentz force. If the magnetic field is large there can be significant return effects when the beam enters a low density material. From the perspective of clinical implementation of any of these products, it would be desirable to account for these dose changes in the treatment planning algorithms. It would be difficult to account for the dose return effects seen at the beam entrance, exit, and tissue interfaces caused by the high magnetic field without using a Monte Carlo planning system. Since the lower magnetic field strengths do not exhibit significant dose perturbation at the entrance and tissue interfaces, it is surmised that a simple correction could be implemented which shifts the dose by a small amount in the direction of the Lorentz force. For the RBP 0.2 T system this correction could be implemented in such a way that the shift is scaled according to the density of the material such that it could account for the larger perturbation seen in the lung phantoms. This correction could be applied after the dose had been calculated to water in much the same way that early inhomogeneity algorithms were implemented. The issue of simple magnetic field correction to dose requires further evaluation.
Additionally, in the RBP geometry the electrons in the penumbra are pushed toward the inferior side of the patient irrespective of the beam orientation in the transverse plane. This results in dose enhancement at the inferior side of the patient and dose reduction at the superior side of the patient. These changes occur over a few cm. The impact of these hot/cold spots can be easily reduced by using a few junction movements during the course of fractionated radiotherapy. Such simplicity is easily afforded in this geometry since the superior-inferior boarders of the coplanar treatment fields tend to be similar irrespective of the orientation in the transverse plane.
V. CONCLUSIONS
This work has, through specific examples, quantified the expected influence a uniform magnetic field will have on dose distribution in the context of two different hybrid MRIlinac geometries: ͑1͒ the RBP geometry where a linac mounted on the open end of a biplanar MRI system results in a B 0 vector that rotates along with the radiation beam with respect to the patient as the gantry angle is varied and ͑2͒ the FC geometry where a stationary solenoidal magnet generates a B 0 vector that remains fixed with respect to the patient as the gantry angle is varied. We have considered both model cases ͑in phantom͒ and in patient brain and lung cases. The simulations using the RBP geometry at a low magnetic field strength ͑0.2 T͒ have demonstrated hot spots limited to a maximum/minimum of Ϯ12% ͑of normalization point dose for a 0.0 T field case͒ in regions where the anatomy allows for the maximal influence of the magnetic field on the electron trajectories ͑lung plan͒. In the case of a four field brain plan, the influence of the magnetic field on dose distribution for the RBP geometry is minimal ͑although not necessarily negligible͒ for low magnetic field strength. In comparison, dose distributions generated in the FC geometry using a magnetic field strength of 1.5 T indicate differences in dose of up to +10% and −5% for the brain plan and +30% and −15% for the lung plan.
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